- CA$233.47m
- CA$278.53m
- CA$90.51m
- 75
- 92
- 73
- 94
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Cash and Short Term Investments | 0.875 | 0.732 | 0.387 | 0.269 | 0.341 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 0.241 | 0.238 | 0.322 | 2.42 | 5.74 |
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Total Assets | 291 | 288 | 348 | 367 | 451 |
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Total Other Current Liabilities | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Total Liabilities | 37.2 | 39.2 | 47 | 57.5 | 76.1 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Total Equity | 254 | 249 | 301 | 310 | 375 |
Total Liabilities & Shareholders' Equity | 291 | 288 | 348 | 367 | 451 |
Total Common Shares Outstanding |